CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- 4 Planned sale Chief Operating Officer sold 3,052 shares at an average $38.52 ($117,571)
- 4 Open-market sale Chief Strategy Officer sold 2,276 shares at an average $38.42 ($87,435)
- 4 Planned sale Director sold 600 shares at $38.74 ($23,244)
- 4 Planned sale Chief Operating Officer sold 2,500 shares at $39.08 ($97,700)
- 4 Planned sale Director sold 7,000 shares at $41.85 ($292,950)
- 4 Open-market sale Director sold 5,015 shares at $41.78 ($209,527)
- 4 Planned sale Director sold 7,000 shares at $40.72 ($285,040)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Lgl & Compliance Officer sold 704 shares at an average $38.49 ($27,094)
- 4 Open-market sale President, Rest of World sold 1,380 shares at $58.00 ($80,040)
- 4 Open-market sale Chief Medical Officer sold 476 shares at $55.70 ($26,513)
- 4 Open-market sale Chief Clinical Officer sold 308 shares at $55.70 ($17,156)
- 4 Open-market sale Director sold 533 shares at $56.95 ($30,354)
- 4 Open-market sale Chief Clinical Officer sold 924 shares at $57.19 ($52,842)
- 4 Option exercise Chief Technical Officer acquired 6,000 shares (option exercise)
- 4 Open-market sale CEO and Chairman sold 25,793 shares at an average $60.56 ($1,561,998)
- 4 Open-market sale Chief Medical Officer sold 17,546 shares at an average $61.39 ($1,077,135)
- 4 Open-market sale Chief Administrative Officer sold 8,618 shares at an average $60.37 ($520,255)
- 4 Open-market sale Chief Clinical Officer sold 362 shares at $61.37 ($22,217)
- 4 Open-market sale Senior Vice President, Finance sold 1,150 shares at $61.37 ($70,580)
Page 8 of 35 · 695 filings